Back
Corvus Pharmaceuticals Stock Predictions
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Buy
56
CRVS
Corvus Pharmaceuticals
Last Price:
8.18
Seasonality Move:
-6.15%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.Corvus Pharmaceuticals Stock Forecast
- Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 61.8% based on the past 8 years of stock performance.
- Corvus Pharmaceuticals has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Corvus Pharmaceuticals Stock Undervalued?
The current Corvus Pharmaceuticals [CRVS] share price is $8.19. The Score for CRVS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. - CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Corvus Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, Corvus Pharmaceuticals has on average historically risen by 61.8% based on the past 8 years of stock performance.
Corvus Pharmaceuticals Stock Rating
Buy
56
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals overpriced?
- Corvus Pharmaceuticals has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Corvus Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corvuspharma.com
52-Week Data
52-Week High:
10.00
52-Week Low:
1.30
Prediction Charts
Market Cap:
512.3M
Price in USD:
8.19
Volume:
2.35M
Beta:
1.07
Technical Analysis
SMA50:
6.77
SMA100:
4.86
SMA200:
3.41
52-Wk Change:
442.38%
Stock Predictions
-
Is Corvus Pharmaceuticals stock public?
Yes, Corvus Pharmaceuticals is a publicly traded company. -
What is the Corvus Pharmaceuticals stock quote today?
The Corvus Pharmaceuticals stock price is 8.19 USD today. -
How to buy Corvus Pharmaceuticals stock online?
You can buy Corvus Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-29 | 8.61 | 8.88 | 8.96 | 8.45 |
| Oct-30 | 9.00 | 8.80 | 9.19 | 8.55 |
| Oct-31 | 8.66 | 8.84 | 9.03 | 8.51 |
| Nov-1 | 8.95 | 9.10 | 9.28 | 8.82 |
| Nov-4 | 8.99 | 9.02 | 9.37 | 7.91 |
| Nov-5 | 8.93 | 9.23 | 9.44 | 8.87 |
| Nov-6 | 9.66 | 8.78 | 9.70 | 8.50 |
| Nov-7 | 8.67 | 8.80 | 9.10 | 8.43 |
| Nov-8 | 8.71 | 9.45 | 9.61 | 8.62 |
| Nov-11 | 9.63 | 9.56 | 9.90 | 9.28 |
| Nov-12 | 9.40 | 8.69 | 9.70 | 8.67 |
| Nov-13 | 9.96 | 8.89 | 10.00 | 8.79 |
| Nov-14 | 8.94 | 8.52 | 9.00 | 7.89 |
| Nov-15 | 8.40 | 8.19 | 8.51 | 7.78 |
Corvus Pharmaceuticals Earnings
Corvus Pharmaceuticals Earnings Report: Per Share Corvus Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corvus Pharmaceuticals Forecast Revenue Growth
Corvus Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Corvus Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.39 per share, and an increase next year of $0.42 per share.
* Corvus Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.